The global biosimilars market was valued at $15.9 billion in 2021, and is projected to reach $143.6 billion by 2031, growing at a CAGR of 24.7% from 2022 to 2031.
Dilated cardiomyopathy (DCM) results from heart enlargement. It is a fetal cardiac disorder, where heart walls become weak and heart fails to pump blood efficiently.
Asia-Pacific Pruritus Therapeutics Market was valued at $2.0 billion in 2022 and is projected to reach $3.2 billion by 2032, registering a CAGR of 4.7% from 2023 to 2032.
North America therapeutic drug monitoring market size was valued at $0.9 billion in 2023 and is projected to reach $2.1 billion by 2035, registering a CAGR of 7.3% from 2024 to 2035
